Healthcare
Live Price
Offline$0.0001
+0.00% today
1Y Change
-66.67%
Window
Jun 23, 2025 → Jun 12, 2026
Coverage: 246 bars · Jun 23, 2025 → Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Winston Pharmaceuticals, Inc. (WPHM) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and down 66.7% across the available one-year price window (Jun 23, 2025 → Jun 12, 2026). Baseline metrics include revenue growth of +208.2%, EPS growth of +60.0%, a dividend yield of 0.0%. What stands out right now is revenue +208.2%, EPS +60.0%, free cash flow -36.4% with operating margin -196.6% and ROIC -561.1%. Valuation is more restrained than many high-expectation growth names at price/sales 0.0. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines WPHM price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
WPHM
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
WPHM Max Drawdown
-66.67%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for WPHM and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$0.0
FY Net Income
-$230.8K
+50.4% YoY
Free Cash Flow
-$37.3K
+64.8% YoY
Revenue Growth
+208.2%
EPS Growth
+60.0%
Gross Margin
99.4%
Net Margin
-190.4%
Income statement
USD
| Metric | 2009 | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|---|
| Revenue | 1M | 453K | 0 | 0 | 0 |
| Gross Profit | 1M | 444K | 0 | -209K | -20K |
| Operating Income | -3M | -5M | -215K | -426K | -218K |
| EBITDA | -3M | -5M | -200K | -418K | -208K |
| Net Income | -3M | -5M | -180K | -465K | -231K |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2009 | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|---|
| Cash & Equivalents | 2M | 6M | 4M | 0 | 159 |
| Total Assets | 2M | 6M | 5M | 0 | 8K |
| Total Liabilities | 1M | 3M | 6M | 625K | 245K |
| Shareholder Equity | 489K | 3M | -1M | -625K | -237K |
| Total Debt | 0 | 0 | 0 | 251K | 171K |
| Net Debt | -2M | -6M | -4M | 251K | 171K |
Cash flow positioning
Latest Full Year
Operating Cash Flow
37K
+64.8% YoY
Capital Expenditures
0
Free Cash Flow
37K
+64.8% YoY
Key ratios
Gross Margin
99.4%
Operating Margin
-196.6%
Net Margin
-190.4%
ROE
-156.0%
Debt / Equity
0.00x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.